Mastodawn

Medicines watchdog to investigate UK peptide clinics over health claims https://www.theguardian.com/society/2026/apr/04/medicines-watchdog-to-investigate-uk-peptide-clinics-over-health-claims #Health #Drugs #UkNews #HealthWellbeing #WeightlossDrugs #LifeAndStyle #Science #Society

Medicines watchdog to investigate UK peptide clinics over health claims

Exclusive: Guardian investigation finds several clinics making potentially unlawful claims about benefits of unregulated therapies

The Guardian

NewsletterTF 1d ago

Pancreatic Cancer: A Looming Shadow or Shifting Sands?

Are new weight loss drugs causing pancreatic cancer? Experts look at smoking and other factors. What you need to know.

#PancreaticCancer, #WeightLossDrugs, #SmokingRisks, #HealthNews, #CancerResearch

https://newsletter.tf/weight-loss-drugs-pancreatic-cancer-risk-smoking/

NewsletterTF 1d ago

Concerns are rising about pancreatic cancer, with some looking at new weight loss drugs, but smoking is still a major cause.

#PancreaticCancer, #WeightLossDrugs, #SmokingRisks, #HealthNews, #CancerResearch
https://newsletter.tf/weight-loss-drugs-pancreatic-cancer-risk-smoking/

New Weight Loss Drugs Linked to Pancreatic Cancer Risk?

Are new weight loss drugs causing pancreatic cancer? Experts look at smoking and other factors. What you need to know.

NewsletterTF

US news | The Guardian 3d ago

US approves new oral weight-loss pill developed by Eli Lilly https://www.theguardian.com/us-news/2026/apr/01/new-weight-loss-pill-glp-1-foundayo #UsNews #WeightlossDrugs #Drugs #Science

US approves new oral weight-loss pill developed by Eli Lilly

Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy

The Guardian

World news | The Guardian 5d ago

Mounjaro maker wants NHS drug price rises in return for more investment in UK https://www.theguardian.com/business/2026/mar/30/mounjaro-maker-eli-lilly-wants-nhs-drug-price-rises-in-return-for-more-investment-in-uk #PharmaceuticalsIndustry #Nhs #Business #ManufacturingSector #UkNews #UsNews #WeightlossDrugs #Health

Mounjaro maker wants NHS drug price rises in return for more investment in UK

US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers

The Guardian

CBC Canada Mar 26

As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss

CBC Health Mar 26

As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss

CBC Top Stories Mar 26

As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss